首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:European addiction research

缩写:EUR ADDICT RES

ISSN:1022-6877

e-ISSN:1421-9891

IF/分区:2.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引706
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Meltem Yılmaz,Aksanur Gökçe,Onur Öztürk Meltem Yılmaz
Background: Cigarette smoking is a major preventable cause of morbidity and mortality worldwide. Despite its well-known harms, epidemiological studies have reported potential protective associations between smoking and ce...
Stijn E Veldman,Niki Lijftogt,Thomas Knuijver et al. Stijn E Veldman et al.
Introduction: Buprenorphine, a partial opioid agonist, is widely used as treatment of opioid use disorder. Traditionally, the original opioids are abruptly stopped, whereafter the buprenorphine is titrated over the course...
Jonathan Uricher Jonathan Uricher
Introduction: The increasing number of refugees in the European Union has led to challenges in terms of allocation and housing. Shared accommodation, which often presents vulnerable living conditions, may exacerbate healt...
Gloria Baumann,Ronald Fischer,Iris Reinhard et al. Gloria Baumann et al.
Pathological gambling (PG) is characterized by altered decision-making. Even though studies have investigated decision-making in patients with PG, the effects of win-contingent stimuli thereon are not well understood yet. Thus, we conducted...
Adalet Yardımcı,Başak Ünübol Adalet Yardımcı
Cryptocurrencies are digital assets that differ from traditional currencies in their unique characteristics. An increasing number of individuals are showing interest in cryptocurrency trading and spending long hours engaged in this activity...
Anne Line Bretteville-Jensen,Linda Nesse Anne Line Bretteville-Jensen
Introduction: Non-prescribed use of opioid agonist treatment (OAT) medications is a public health concern. This study analyses the prevalence of non-prescribed use and non-fatal overdoses in Norway in 2013 and 2023, a per...
Anne Marciuch,Regina Skar-Fröding,Kristin Klemmetsby Solli et al. Anne Marciuch et al.
Background: Personal recovery is an important target in mental health care settings and has been suggested as the "bridging principle" between mental health care and substance use disorder (SUD) treatment. However, few ps...
Aishwarya Ghosh,Simon Erridge,Ross Coomber et al. Aishwarya Ghosh et al.
Background: With a global rise in opioid-related mortality, comes a need to address this with novel therapies. Cannabinoid receptors are highly expressed and co-localised with opiate receptors of the mesolimbic system. Ca...
Lars Henrik Ryther Myklebust,Desiree Eide,Linda Elise C Wüsthoff et al. Lars Henrik Ryther Myklebust et al.
Introduction Norway's HAT project started in 2022, aimed at targeting individuals with severe opioid use disorder (OUD) who did not benefit from first-line, conventional opioid agonist treatment (OAT). The use of pharmaceutical diacetylmorp...
Anna R Basińska-Szafrańska Anna R Basińska-Szafrańska
Introduction: Despite extreme inter-patient differences in the benzodiazepine (BZD) metabolism rate, patients dependent on BZDs or other GABA-A receptor modulators are treated without laboratory control. The proposed deto...